Vnitr Lek 2008, 54(6):665-669

Acute cholestasis following treatment with nimesulide and oral contraception: case report and review

T. Koller1,*, A. Baňárová1, F. Ondriaš2, J. Kollerová1, J. Payer1
1 V. interná klinika Lekárskej fakulty UK a FNsP Bratislava, Slovenská republika, prednosta prof. MUDr. Juraj Payer, CSc.
2 Patológia Ružinov, Alpha medical patológia s.r.o., Bratislava, Slovenská republika, prednosta prim. doc. MUDr. František Ondriaš, CSc.

Our case report of acute cholestatic liver injury highlights the potential hepatotoxicity of nimesulide treatment in combination with oral contraception. Rarely occuring histological findings of "pure" cholestasis without any inflammatory or necrotic changes with favourable outcome following ursodeoxycholic acid administration are described. It was not possible to distinguish the separate role of any of these two drugs on hepatotoxicity according to the available information. Based on the known similarities in hepatotoxic profile of nimesulide and oral contraceptives, it can be assumed that their interaction could increase the risk of liver damage, although the precise mechanisms are not ellucidated yet. Nimesulide toxicity however is often reported in cases taking several potentially hepatotoxic drugs. It is therefore prudent to reconsider any concommitant treatment and closely monitor liver function tests in patients requiring nimesulide treatment.

Keywords: nimesulide; oral contraception; cholestasis; hepatotoxicity

Received: February 19, 2008; Accepted: March 20, 2008; Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koller T, Baňárová A, Ondriaš F, Kollerová J, Payer J. Acute cholestasis following treatment with nimesulide and oral contraception: case report and review. Vnitr Lek. 2008;54(6):665-669.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Dastis SN, Rahier J, Lerut J et al. Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound. Eur J Gastroenterol Hepatol 2007; 19: 919-922. Go to original source... Go to PubMed...
    2. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 11: 1323-1330. Go to original source... Go to PubMed...
    3. Biour M, Ben Salem C, Chazouillères O et al. Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs. Gastroenterol Clin Biol 2004; 8-9: 720-759. Go to original source... Go to PubMed...
    4. Velayudham LS, Farrell GC. Drug-induced cholestasis. Expert Opin Drug Saf 2003; 3: 287-304. Go to original source... Go to PubMed...
    5. Boelsterli UA. Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf 2002; 9: 633-648. Go to original source... Go to PubMed...
    6. Rodrigo L, de Francisco R, Pérez-Pariente JM et al. Nimesulide-induced severe hemolytic anemia and acute liver failure leading to liver transplantation. Scand J Gastroenterol 2002; 11: 1341-1343. Go to original source... Go to PubMed...
    7. McCormick PA, Kennedy F, Curry M et al. COX 2 inhibitor and fulminant hepatic failure. Lancet 1999; 353: 40-41. Go to original source... Go to PubMed...
    8. Tan HH, Ong WM, Lai SH et al. Nimesulide-induced hepatotoxicity and fatal hepatic failure. Singapore Med J 2007; 6: 582-585.
    9. Merlani G, Fox M, Oehen HP et al. Fatal hepatoxicity secondary to nimesulide. Eur J Clin Pharmacol 2001; 4: 321-326. Go to original source... Go to PubMed...
    10. Ozgür O, Hacihasanoğlu A, Karti SS et al. Nimesulide-induced fulminant hepatitis. Turk J Gastroenterol 2003; 3: 208-210.
    11. Van Steenbergen W, Peeters P, De Bondt J et al. Nimesulide-induced acute hepatitis: evidence from six cases. J Hepatol 1998; 29: 135-141. Go to original source... Go to PubMed...
    12. Belovičová M, Hrušovský Š, Piják M et al. Poškodenie pečene nimesulidom u pacientky s autoimunitnou hepatitídou. Lek Obz 2006; 7-8: 341-344.
    13. Giannattasio A, D'Ambrosi M, Volpicelli M et al. Steroid therapy for a case of severe drug-induced cholestasis. Ann Pharmacother 2006; 40: 1196-1199. Go to original source... Go to PubMed...
    14. Su B, Landini S, Davis DD et al. Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells. J Med Chem 2007; 50: 1635-1644. Go to original source... Go to PubMed...
    15. King RS, Ghosh KA, Wu J. Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents. Curr Drug Metab 2006; 7: 745-753. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.